Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:26 AM
Ignite Modification Date:
2025-12-25 @ 12:26 AM
NCT ID:
NCT02551458
Eligibility Criteria:
Inclusion Criteria:
* Epidermoid carcinoma (EC) or adenocarcinoma of the thoracic oesophagus or adenocarcinoma of the oesogastric junction (Siewert type I or II) proven histologically
* Stage cT2 N1-3 M0 or cT3-T4a N0 or N1-3 M0 after a full investigation
* Patient considered operable with a curative intent and scheduled to undergo first-line radiochemotherapy in a multidisciplinary meeting
* Age ≥ 18 years \< 75 years
* Patient with national health insurance cover and who has provided written informed consent for the clinical and biological studies.
Exclusion Criteria:
* Cancer of the cervical oesophagus (15 to 19 cm from the dental arches)
* Weight loss \> 15% at the recruitment with no improvement after nutritional support
* Serious comorbidity threatening survival in the short term
* Contra-indication for radiochemotherapy
* Other uncured malignant disease in the 5 previous years (except for in situ cervical carcinoma and treated non-melanotic skin cancers)
* Absence of effective contraception in patients (men or women) able to procreate, pregnant or breast-feeding women
* Impossibility to follow the trial
* Legal disqualification (patients in custody or under guardianship)
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT02551458
Study Brief:
Protocol Section:
NCT02551458